New Zealand markets open in 29 minutes

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
97.63+0.62 (+0.64%)
As of 03:31PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 198.80B
Enterprise value 211.29B
Trailing P/E 25.13
Forward P/E 13.81
PEG ratio (5-yr expected) 0.93
Price/sales (ttm)3.78
Price/book (mrq)5.22
Enterprise value/revenue 3.90
Enterprise value/EBITDA 10.90

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 38.00%
S&P500 52-week change 311.63%
52-week high 3105.61
52-week low 379.98
50-day moving average 396.66
200-day moving average 397.13

Share statistics

Avg vol (3-month) 31.48M
Avg vol (10-day) 31.63M
Shares outstanding 52.06B
Implied shares outstanding 62.07B
Float 81.96B
% held by insiders 10.00%
% held by institutions 18.04%
Shares short (14 Nov 2023) 43.65M
Short ratio (14 Nov 2023) 42.36
Short % of float (14 Nov 2023) 4N/A
Short % of shares outstanding (14 Nov 2023) 40.19%
Shares short (prior month 12 Oct 2023) 43.22M

Dividends & splits

Forward annual dividend rate 43.5
Forward annual dividend yield 43.61%
Trailing annual dividend rate 33.46
Trailing annual dividend yield 33.57%
5-year average dividend yield 43.56
Payout ratio 490.64%
Dividend date 319 Mar 2023
Ex-dividend date 408 Mar 2023
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin 14.45%
Operating margin (ttm)28.53%

Management effectiveness

Return on assets (ttm)8.75%
Return on equity (ttm)16.45%

Income statement

Revenue (ttm)54.22B
Revenue per share (ttm)25.84
Quarterly revenue growth (yoy)12.10%
Gross profit (ttm)36.74B
EBITDA 21.59B
Net income avi to common (ttm)8.15B
Diluted EPS (ttm)3.86
Quarterly earnings growth (yoy)12.00%

Balance sheet

Total cash (mrq)12.82B
Total cash per share (mrq)6.24
Total debt (mrq)25.19B
Total debt/equity (mrq)65.86%
Current ratio (mrq)0.94
Book value per share (mrq)18.57

Cash flow statement

Operating cash flow (ttm)15.37B
Levered free cash flow (ttm)22.39B